These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


416 related items for PubMed ID: 16130111

  • 1. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.
    Pramstaller PP, Schlossmacher MG, Jacques TS, Scaravilli F, Eskelson C, Pepivani I, Hedrich K, Adel S, Gonzales-McNeal M, Hilker R, Kramer PL, Klein C.
    Ann Neurol; 2005 Sep; 58(3):411-22. PubMed ID: 16130111
    [Abstract] [Full Text] [Related]

  • 2. Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.
    Chien HF, Rohé CF, Costa MD, Breedveld GJ, Oostra BA, Barbosa ER, Bonifati V.
    Neurogenetics; 2006 Mar; 7(1):13-9. PubMed ID: 16328510
    [Abstract] [Full Text] [Related]

  • 3. Lewy bodies and parkinsonism in families with parkin mutations.
    Farrer M, Chan P, Chen R, Tan L, Lincoln S, Hernandez D, Forno L, Gwinn-Hardy K, Petrucelli L, Hussey J, Singleton A, Tanner C, Hardy J, Langston JW.
    Ann Neurol; 2001 Sep; 50(3):293-300. PubMed ID: 11558785
    [Abstract] [Full Text] [Related]

  • 4. Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation.
    Sharp ME, Marder KS, Côté L, Clark LN, Nichols WC, Vonsattel JP, Alcalay RN.
    Mov Disord; 2014 Apr; 29(4):566-8. PubMed ID: 24375549
    [Abstract] [Full Text] [Related]

  • 5. A multidisciplinary study of patients with early-onset PD with and without parkin mutations.
    Lohmann E, Thobois S, Lesage S, Broussolle E, du Montcel ST, Ribeiro MJ, Remy P, Pelissolo A, Dubois B, Mallet L, Pollak P, Agid Y, Brice A, French Parkinson's Disease Genetics Study Group.
    Neurology; 2009 Jan 13; 72(2):110-6. PubMed ID: 18987353
    [Abstract] [Full Text] [Related]

  • 6. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N.
    Rinsho Shinkeigaku; 2004 Jan 13; 44(4-5):241-62. PubMed ID: 15287506
    [Abstract] [Full Text] [Related]

  • 7. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
    Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Ondo WG, Allen FH, Scott BL, Goetz CG, Small GW, Mastaglia F, Stajich JM, Zhang F, Booze MW, Winn MP, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM.
    Ann Neurol; 2003 May 13; 53(5):624-9. PubMed ID: 12730996
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.
    Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Ross BM, Cote LJ, Frucht S, Ford B, Alcalay RN, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Neils GD, Verbitsky M, Kisselev S, Caccappolo E, Ottman R, Clark LN.
    Arch Neurol; 2010 Jun 13; 67(6):731-8. PubMed ID: 20558392
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease.
    Ghione I, Di Fonzo A, Saladino F, Del Bo R, Bresolin N, Comi GP, Rango M.
    Neurotoxicology; 2007 May 13; 28(3):698-701. PubMed ID: 17335904
    [Abstract] [Full Text] [Related]

  • 12. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.
    Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J, Factor SA, Yu CE, Montimurro JS, Keefe RG, Schellenberg GD, Payami H.
    Ann Neurol; 2007 Jan 13; 61(1):47-54. PubMed ID: 17187375
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phenotypic variability of parkin mutations in single kindred.
    Koentjoro B, Park JS, Ha AD, Sue CM.
    Mov Disord; 2012 Sep 01; 27(10):1299-303. PubMed ID: 22807239
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.
    Deng H, Le WD, Hunter CB, Ondo WG, Guo Y, Xie WJ, Jankovic J.
    Arch Neurol; 2006 Feb 01; 63(2):273-7. PubMed ID: 16476817
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease.
    Sinha R, Racette B, Perlmutter JS, Parsian A.
    Parkinsonism Relat Disord; 2005 Sep 01; 11(6):341-7. PubMed ID: 16019250
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene.
    Hayashi S, Wakabayashi K, Ishikawa A, Nagai H, Saito M, Maruyama M, Takahashi T, Ozawa T, Tsuji S, Takahashi H.
    Mov Disord; 2000 Sep 01; 15(5):884-8. PubMed ID: 11009195
    [Abstract] [Full Text] [Related]

  • 19. Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation.
    Tan LC, Tanner CM, Chen R, Chan P, Farrer M, Hardy J, Langston JW.
    Mov Disord; 2003 Jul 01; 18(7):758-63. PubMed ID: 12815654
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.